SCHEMBL14123744

SCHEMBL14123744

C=CC(=O)OCCN(C(=O)N(C)c1ccc(C)c(N(C)C(=O)N(CCOC(=O)C=C)c2ccccc2)c1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.39
MEN1 O00255 7/20 0.35
KMT2A Q03164 7/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 3/20 0.33
TP53 P04637 2/20 0.33
PSMB5 P28074 2/20 0.33
TSHR P16473 2/20 0.33
GLA P06280 1/20 0.33
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31
PDK4 Q16654 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14123772 0.88 THRB (0.45) THRBMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14123725 0.88 THRB (0.47) THRBMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14123765 0.86 THRB (0.48) THRBMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14123741 0.84 KMT2A (0.43) THRBMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14123740 0.82 THRB (0.42) THRBSMN1; SMN2ALDH1A1TSHRGLA
SCHEMBL14123739 0.81 TSHR (0.48) THRBSMN1; SMN2TSHR
SCHEMBL14123746 0.81 THRB (0.41) THRBMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14123777 0.81 THRB (0.43) THRBMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14123774 0.80 HSD17B1 (0.39) THRBALDH1A1TP53
SCHEMBL14123767 0.80 THRB (0.54) THRBMEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962227-B2 Electrophotographic photosensitive member, process cartridge, electrophotographic apparatus, method of producing electrophotographic photosensitive member, and urea compound CANON KABUSHIKI KAISHA (JP) 2015-02-24 US disclosed
US-20120301177-A1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, ELECTROPHOTOGRAPHIC APPARATUS, METHOD OF PRODUCING ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, AND UREA COMPOUND CANON KABUSHIKI KAISHA (JP) 2012-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120301177-A1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, ELECTROPHOTOGRAPHIC APPARATUS, METHOD OF PRODUCING ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, AND UREA COMPOUND SLC14A1, ITCH, UROD THRB 4300/4885MEN1 3706/4885KMT2A 3761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.